4//SEC Filing
Christopher Nishan Garabedian 4
Accession 0001181431-12-047604
CIK 0000873303other
Filed
Aug 26, 8:00 PM ET
Accepted
Aug 27, 9:29 PM ET
Size
8.2 KB
Accession
0001181431-12-047604
Insider Transaction Report
Form 4
Christopher Nishan Garabedian
Director
Transactions
- Award
Stock Appreciation Right
2012-08-23+70,000→ 70,000 totalExercise: $10.08Exp: 2022-08-23→ Common Stock (70,000 underlying) - Award
Stock Option (Right to Buy)
2012-08-23+150,000→ 150,000 totalExercise: $10.08Exp: 2022-08-23→ Common Stock (150,000 underlying)
Footnotes (2)
- [F1]25% of the shares subject to the option will vest and become exercisable on the one (1) year anniversary of August 23, 2012 (the "Vesting Commencement Date"), and 1/48th of the total number of shares will vest and become exercisable in equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
- [F2]25% of the shares subject to the stock appreciation right (SAR) will vest and become exercisable on the one (1) year anniversary of August 23, 2012 (the "Vesting Commencement Date"), and 1/48th of the total number of shares will vest and become exercisable in equal monthly installments thereafter, such that 100% of the shares subject to the SAR will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
Documents
Issuer
Sarepta Therapeutics, Inc.
CIK 0000873303
Entity typeother
Related Parties
1- filerCIK 0001492604
Filing Metadata
- Form type
- 4
- Filed
- Aug 26, 8:00 PM ET
- Accepted
- Aug 27, 9:29 PM ET
- Size
- 8.2 KB